RIKEN researchers have discovered how a single mutation in one gene can simultaneously result in two symptoms—a severely ...

In just over a year since its US Food and Drug Administration (FDA) approval, pirtobrutinib (Jayprica) has become a standard therapy for patients with chronic lymphocytic leukemia (CLL ...

HealthDay News — Relative to high-dose doxycycline, low-dose doxycycline is comparably effective but more tolerable for lymphocytic scarring alopecias, according to a research letter published online ...

Minimal residual disease negativity was achieved at a significantly higher rate with venetoclax-based therapies, supporting its role in CLL. Venetoclax-containing regimens demonstrated superior ...

1 Biomedical Institute for Multimorbidity, Centre for Biomedicine, Hull York Medical School, Faculty of Health Sciences, University of Hull, Hull, United Kingdom 2 Department of Haematology, Castle ...